Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN).
Elizabeth AhernAnnette CubittEmma BallardMichele W L TengWilliam C DougallMark J SmythDavid GodboltRishendran NaidooAmanda GoldrickBrett G M HughesPublished in: Trials (2019)
Prospectively registered on Australian New Zealand Clinical Trials Registry (ACTRN12618001121257) on 06/07/2018.
Keyphrases